Showing results (1-10 of 190) with videos related to
Sort By:
Pageof 19
Clinical and Experimental Immunology|December 1, 1983
Immune adherence and staphylococcus protein A binding of soluble immune complexes produced by complement activationJ A Schifferli, D K PetersClinical and Experimental Immunology|March 1, 1982
Complement-mediated inhibition of immune precipitation. II. Analysis by sucrose density gradient ultracentrifugationJ A Schifferli, D K PetersLancet (London, England)|October 22, 1983
Complement, the immune-complex lattice, and the pathophysiology of complement-deficiency syndromesJ A Schifferli, D K PetersClinical and Experimental Immunology|March 1, 1982
Complement-mediated inhibition of immune precipitation. I. Role of the classical and alternative pathwaysJ A Schifferli, P Woo, D K PetersClinical and Experimental Immunology|November 1, 1980
Inhibition of immune precipitation by complementJ A Schifferli, S R Bartolotti, D K PetersComplement (Basel, Switzerland)|January 1, 1984
C4-binding protein in sera of patients with systemic lupus erythematosus and mixed essential cryoglobulinemiaJ A Schifferli, A Bakkaloglu, N Amos, et al.Clinical and Experimental Immunology|December 1, 1981
Complement-mediated solubilization in patients with systemic lupus erythematosus, nephritis or vasculitisJ A Schifferli, S M Morris, A Dash, et al.Clinical and Experimental Immunology|February 1, 1983
Metabolism of IgG in type II mixed essential cryoglobulinaemia--autologous cryoprecipitated and normal homologous IgG are incorporated into complexes and metabolized in vivo at similar ratesJ A Schifferli, N Amos, C D Pusey, et al.Immunology Letters|February 1, 1987
The classical pathway of complement prevents the formation of insoluble antigen-antibody complexes: biological implicationsJ A SchifferliTherapeutische Umschau. Revue Therapeutique|June 11, 2005
[Systemic lupus erythematosus--myths and dogma]J A SchifferliPageof 19